Vice President Science & Product Development, Kappa Bioscience AS
Dr Bergeland has a broad experience in research, development and documentation within the nutraceutical and pharmaceutical industry. Before joining Kappa Bioscience, Dr Bergeland was responsible for the clinical documentation program in Aker BioMarine. He has several years’ experience from management of clinical research from Clavis Pharma and LINK Medical research. He earned his Ph.D. and had his postdoctoral education at Centre of Immune Regulation (University of Oslo, Norway).